Zydus Lifesciences Launches PEPAIR, India’s First Affordable OPEP Device
Filing Summary
Zydus Lifesciences Ltd has introduced PEPAIR, India’s first affordable Oscillating Positive Expiratory Pressure (OPEP) device, priced at Rs. 990 per unit. This drug-free, handheld device is designed to aid patients with COPD, asthma, and bronchiectasis by improving respiratory health. The device is launched in collaboration with AeroDel Technology Innovations Pvt. Ltd. PEPAIR aims to address the accessibility gap in respiratory care due to its affordability. Zydus continues to expand its respiratory portfolio, leveraging its established presence in oral and inhalation therapies.
Zydus Lifesciences Ltd has announced the launch of PEPAIR, a handheld, drug-free device designed to improve respiratory health. This device is the first of its kind in India, offering an affordable solution for patients with chronic respiratory conditions such as COPD, asthma, and bronchiectasis. The device is priced at Rs. 990 per unit and is developed in collaboration with AeroDel Technology Innovations Pvt. Ltd.
The financial terms of the launch include the pricing of the PEPAIR device at Rs. 990 per unit, making it accessible to a larger patient base. The affordability of this device is a strategic move to bridge the gap in respiratory care access, which has been limited due to cost constraints. The collaboration with AeroDel Technology Innovations Pvt. Ltd is a key component of this launch, leveraging their expertise in developing patient-centric respiratory devices.
The PEPAIR device features a 3-resistance system designed to help clear congestion, support effective mucous clearance, and improve breathing. It utilizes Oscillating Positive Expiratory Pressure (OPEP) therapy, which creates pressure and vibrations during exhalation to loosen mucous and open airways. This technology is recommended in clinical guidance for airway clearance but has been limited in practice due to affordability issues. The device’s design aims to address these challenges, providing an effective solution for everyday respiratory care.
In the context of the Indian market, respiratory diseases are on the rise due to factors such as air pollution, climate changes, and urbanization. Zydus Lifesciences is a significant player in the respiratory segment, with a strong presence in oral and inhalation therapies. The company leads the oral bronchodilator segment with products like Deriphyllin and has an extensive inhalation portfolio. The introduction of PEPAIR aligns with Zydus’s strategy to expand its offerings in respiratory health.
The launch of PEPAIR is effective immediately, with the device available for purchase at the stated price. The collaboration with AeroDel Technology Innovations Pvt. Ltd plays a crucial role in the development and manufacturing of the device. AeroDel focuses on creating scalable and affordable respiratory solutions, enhancing access to care in India and globally.
AeroDel Technology Innovations Pvt. Ltd is the innovator behind the OPEP device platform for PEPAIR. The company specializes in developing respiratory devices that are patient-centric and affordable. Supported by various government and entrepreneurial initiatives, AeroDel aims to improve access to respiratory care in India and beyond.
Zydus Lifesciences Ltd is an innovation-driven global life sciences company. It focuses on discovering, developing, and marketing a wide range of healthcare therapies. With a workforce of over 29,000 employees, including 1,500 scientists, Zydus is committed to advancing healthcare through quality solutions. The company continues to introduce innovative products to address unmet healthcare needs.